Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Developing Kryptonite for Superbug

13.11.2007
University of Idaho researchers are crossing academic and geographical bounds to develop more effective defenses against Staphylococcus aureus bacteria and other deadly pathogens.

One of the goals of that effort is to create much faster and more accurate identification of strains resistant to the antibiotic methicillin, formally known as methicillin-resistant Staphylococcus aureus, or MRSA.

Breakthrough detection technologies are already in hand in University of Idaho labs. Nanoelectronic biosensors at the university’s Center for Advanced Microelectronics and Biomolecular Research (CAMBR) recently have cut detection time for staph from the industry standard of up to three days down to three hours.

Researchers now are focused on tweaking the device so that it can provide a complete toxin profile of staph that will quickly reveal the virulence of infections. To accomplish that goal, researchers from the university’s Center of Biomedical Research Excellence (COBRE) are partnering with CAMBR scientists.

... more about:
»CAMBR »MRSA »NMS »hospitals »superbug

Eventually, it is hoped that even the hard-to-identify MRSA bacteria will be detected quickly using some iteration of the nanotechnology.

MRSA’s resistance to antibiotics has earned it “superbug” status. It is responsible for more 94,000 infections and 16,000 deaths annually in the U.S. alone, according to recent Center for Disease Control reports. Those numbers indicate it is a greater health threat to Americans than the AIDS virus.

The spiking MRSA death toll recently reported by the Center for Disease Control presents formidable motivation to move infectious disease research ahead, and to get life saving nanotechnologies into the marketplace. University of Idaho scientists are focused on both goals.

The CAMBR Biosensor

The vast majority of hospitals, including all regional facilities in Coeur d’Alene, Idaho, and Spokane, Wash., still culture staph in Petri dishes. The culture usually takes one to two days to mature until it is identifiable. CAMBR biosensors identify staph within three hours, with an equally astounding increase in accuracy. The device already has successfully detected the staphylococcus aureus 16S rRNA gene, 16S rRNA, and enterotoxin B, as well as a biomark for lung cancer.

“Our electronic detection capability is approximately 1,000 times more sensitive than the chemilumine technologies currently being used in clinical laboratories,” said Wusi Maki, principal investigator for CAMBR biomolecular research.

“Our plan is to work with Professor Greg Bohach and use the nanosensor CAMBR has developed to provide a toxin profile that will tell us very quickly, and very accurately, if we are looking at lethal or just mild staph,” said Maki.

Bohach is principal investigator and director of the COBRE in the university’s Department of Microbiology, Molecular Biology and Biochemistry (MMBB).

There currently is no method available to quickly and accurately judge the virulence of staph bacteria, Bohach noted.

Finding effective “capture molecules,” those that adhere specifically to staph and its toxins, is key to creating a biosensor-generated toxin profile and insights into the virulence of specific staph infections.

Finding an RNA Fragment in a Molecular Library Stack

University of Idaho MMBB graduate student Ryan Dobler has been working with Bohach and scientists at CAMBR labs to identify and replicate capture molecules. Specifically, he has been searching through a vast molecular library looking for an aptamer molecule, “a piece of RNA that binds to a target,” Dobler explained.

His work has confirmed that the large pool of RNA fragments he studied are binding; specifically, that they attach to fibronectin binding protein. “Fibronectin binding protein is a unique protein that’s found on the surface of staph bacteria,” Dobler said. “It helps bind the staph to human tissue.”

The research has not yet yielded an aptamer that would most effectively and most specifically recognize staph. In his year-long investigation, Dobler tested about 80 samples among the thousands that may yield results.

He is writing up his research, and will present his findings in his master’s thesis in December. Bohach, Maki and their teams hope to find funding to continue the study.

“A good example of capture molecules are those that attach themselves to the toxins that staph makes,” Bohach explained. “We hope to identify particularly those toxins that are associated with the more virulent strains, including MRSA strains. There’s quite a bit known about the toxins, and we can – in a limited number of steps – screen and isolate staph for many different toxins at the same time.”

“So if you’re looking specifically for MRSA, you could look for those bacterial molecules that are associated with it, and through that unique association, identify it with precision,” he said.

As the research progresses, capture molecules for a variety of identifying toxins will be incorporated onto the biosensor, which will quickly read and accurately translate the toxin profile.

Using staph Pathogenesis as a Treatment Delivery System

Bohach and others members of his team also are looking at the mechanisms staph bacteria employ to enter host cells and proliferate.

Using nanowires and other nanomaterials (NMs), they aim to hijack the methods bacteria use for toxin delivery, and use them to deliver drug therapies specifically to infected cells.

Bohach is working with University of Idaho professor of physics and materials engineer David McIlroy, microbiologist Carolyn Hovde and others to develop nanowires and other nanomaterials (NMs) for use as innovative drug delivery systems.

McIlroy leads a team of seven researchers supported by the university’s Blue Ribbon Strategic Initiative funding. Their goal is to integrate nanonmaterials research with cell biology and bioscience research.

The Idaho researchers have found that NMs penetrate tumors easily, and can do so coated with antibodies or other materials that seek and destroy infected cells, while sparing normal cells.

They are looking for ways to enable NMs to more readily penetrate the targeted cells, and they report that nanowires coated with the protein fibronectin penetrate cells more easily than uncoated nanowires. In experiments with human and animal cells, they have illustrated that coated nanowires can enter and deliver a toxic agent (StxA1) that kills the cells.

Microbiologists Bohach and Hovde work with CAMBR scientists including: Maki, biochemist; Shiva Restage, organic chemist; Miramar Mishap, surface chemist and nanofabrication expert; and Brian Filanoski, a biochemist studying optical detection of bio-agents.

University of Idaho CAMBR biosensor breakthroughs have recently generated two patent applications. The technology is at the demonstration phase and work is needed to bring it to a marketable system, said Maki. “All the building blocks are in place to produce a real system. With the right investment and focus, the technology could be made ready by the teams in Post Falls and Moscow in a few years," she said.

The technology developers have experience delivering commercial technologies, and that task is within the charter of the CAMBR organization, she added.

Once developed and adopted for use in hospitals, biosensors would impact both those who test positive and those who test negative for the bacteria. For the duration of the current one to three day wait for a staph culture, hospitals must isolate the patient. Insurance seldom covers that expense, so patients and hospitals currently pick up the hefty tab.

“There is an immediate need for faster, more accurate staph detection,” said Maki. “Quick identification in hospitals could save many lives, and millions of dollars.”

Joni Kirk | EurekAlert!
Further information:
http://www.uidaho.edu

Further reports about: CAMBR MRSA NMS hospitals superbug

More articles from Life Sciences:

nachricht Tag it EASI – a new method for accurate protein analysis
19.06.2018 | Max-Planck-Institut für Biochemie

nachricht How to track and trace a protein: Nanosensors monitor intracellular deliveries
19.06.2018 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

New material for splitting water

19.06.2018 | Physics and Astronomy

Cementless fly ash binder makes concrete 'green'

19.06.2018 | Materials Sciences

Overdosing on Calcium

19.06.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>